Bal Pharma

14
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
73.96
-0.61 (-0.82%)
BSENSE

Dec 05

BSE+NSE Vol: 3.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
303.00
339.00
304.00
281.00
250.00
171.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
303.00
339.00
304.00
281.00
250.00
171.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-1.00
-17.00
-4.00
5.00
3.00
Raw Materials Consumed
164.00
192.00
190.00
172.00
145.00
81.00
Power & Fuel Cost
8.00
8.00
7.00
5.00
4.00
4.00
Employee Cost
62.00
60.00
55.00
47.00
41.00
50.00
Operating Expenses
10.00
13.00
13.00
10.00
8.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
12.00
9.00
12.00
12.00
8.00
8.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
1.00
2.00
3.00
3.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
273.00
308.00
278.00
257.00
225.00
166.00
Operating Profit (PBDIT) excl Other Income
29.00
30.00
25.00
23.00
24.00
5.00
Other Income
2.00
2.00
0.00
5.00
1.00
1.00
Operating Profit (PBDIT)
31.00
33.00
26.00
28.00
25.00
6.00
Interest
17.00
14.00
12.00
10.00
12.00
12.00
Profit before Depriciation and Tax
14.00
19.00
13.00
18.00
13.00
-5.00
Depreciation
9.00
10.00
9.00
9.00
9.00
7.00
Profit Before Taxation & Exceptional Items
5.00
9.00
4.00
9.00
4.00
-13.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
5.00
9.00
4.00
9.00
4.00
-13.00
Provision for Tax
-2.00
1.00
2.00
3.00
0.00
0.00
Profit After Tax
7.00
7.00
2.00
5.00
4.00
-12.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
22.00
14.00
13.00
9.00
12.00
26.00
Profit Available for appropriations
29.00
22.00
16.00
15.00
17.00
14.00
Appropriations
29.00
22.00
16.00
15.00
17.00
14.00
Equity Dividend (%)
12.00%
12.00%
10.00%
10.00%
10.00%
0.00%
Earnings Per Share
4.54
4.96
1.67
3.79
3.34
-8.62
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -10.65% vs 11.51% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -3.80% vs 22.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.29% vs 19.10% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -2.81% vs 184.26% in Mar 2024

Compare Profit and Loss Results of Bal Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
303.00
0
303.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
303.00
0
303.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0
-7.00
0%
Raw Materials Consumed
164.00
0
164.00
0%
Power & Fuel Cost
8.00
0
8.00
0%
Employee Cost
62.00
0
62.00
0%
Operating Expenses
10.00
0
10.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
12.00
0
12.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
273.00
0
273.00
0%
Operating Profit (PBDIT) excl Other Income
29.00
0.00
29.00
0%
Other Income
2.00
0
2.00
0%
Operating Profit (PBDIT)
31.00
0
31.00
0%
Interest
17.00
0
17.00
0%
Profit before Depriciation and Tax
14.00
0
14.00
0%
Depreciation
9.00
0
9.00
0%
Profit Before Taxation & Exceptional Items
5.00
0
5.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
5.00
0
5.00
0%
Provision for Tax
-2.00
0
-2.00
0%
Profit After Tax
7.00
0
7.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
22.00
0
22.00
0%
Profit Available for appropriations
29.00
0
29.00
0%
Appropriations
29.00
0
29.00
0%
Equity Dividend (%)
12%
0%
12.00
Earnings Per Share
4.54
0
4.54
0%
Profit And Loss - Net Sales
Net Sales 303.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.65% vs 11.51% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.76 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.80% vs 22.52% in Mar 2024

Profit And Loss - Interest
Interest 17.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.29% vs 19.10% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.81% vs 184.26% in Mar 2024